ClinicalTrials.gg
Enrolling by invitationNCT06114368Updated Oct 15, 2024

Endoscopic Flexor Hallucis Longus Transfer vs Minimally Invasive Repair in Acute Achilles Tendon Rupture

An observational study in Achilles Tendon Rupture, Achilles Tendon Surgery and Achilles Tendon Injury, sponsored by Aristotle University Of Thessaloniki. Enrolling by invitation at 1 site in Greece. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Aristotle University Of Thessaloniki · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
40
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of this observational study is to compare the outcomes of two different surgical techniques (Endoscopic Flexor Hallucis Longus transfer - Group 1 vs Minimally Invasive primary repair - Group 2) for patients with acute Achilles tendon rupture. The main questions to be answered are:

  1. Which group's patients are more satisfied?
  2. Which group's patients appear to have a greater complication rate?
  3. Which group's patients have greater calf and ankle circumference compared to the unaffected limb?
  4. Which group's patients have greater passive and active range of ankle motion compared to the unaffected limb?
  5. Are group 1 patients characterized by strength deficit in hallux flexion power?
Read the detailed description

Two separate foot and ankle surgeons in Northern Greece prefer to use a different surgical technique in their respective patients with Acute Achilles tendon rupture.

The first one (A.E.) prefers to perform only Endoscopic Flexor Hallucis Longus transfer, while the second one (P.S.) prefers to perform only Minimally invasive primary repair assisted by the Achillon device (Percutaneous Achilles Repair System - PARS). They both agreed to enroll their recently operated patients (last 5 years) in this retrospective study, which will be conducted by the researcher (M.K.). The patient's study may be retrospective, nevertheless, the patients were randomly chosen and enrolled by a prospectively designed study protocol. Each surgeon applied the respective surgical treatment modality regardless of each patient's characteristics, biometrics, or comorbidities. Inclusion and Elimination criteria will be applied. The patient's satisfaction will be evaluated with the Achilles Tendon Total Rupture Score (ATRS). Complications will be documented. Calf and ankle circumference will be measured and compared to the contralateral healthy limb. Ankle passive and active range of motion will be measured and compared to the contralateral healthy limb. Possible correlations will be investigated regarding patient age, BMI, history of smoking, level of activity, and comorbidities.

02

Conditions studied

  • Achilles Tendon Rupture
  • Achilles Tendon Surgery
  • Achilles Tendon Injury

Browse trials for

Keywords

  • Achilles tendon
  • rupture
  • Endoscopic
  • Flexor Hallucis Longus transfer
  • repair
  • Percutaneous Achilles Repair System - PARS
  • Minimally invasive
03

In context

Rupture

78 studies on the registry are indexed under Rupture; 17 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 31 observational studies indexed under Rupture.

Browse Rupture studies →

Lead sponsor

Aristotle University Of Thessaloniki is the lead sponsor of 282 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients with Achilles tendon rupture operated exclusively with these two surgical techniques, by these two particular surgeons (A.E. and P.S.) in their respective hospitals (General Hospital of Naoussa, St Luke's Hospital).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed Consent Form
  • Age between 18-75 years
  • Acute Achilles Tendon Rupture (\<3 weeks)
  • Surgical Management with Endoscopic Flexor Hallucis Longus transfer or Minimally Invasive primary tendon repair
  • More than 12 months postoperative follow-up
  • Patients operated after 2015

Exclusion criteria

Exclusion Criteria:

  • Inability or Unwillingness to cooperate
  • Medically unfit for examination (e.g. due to terminal illness)
  • Age less than 18 or more than 75 years
  • Non-operative Management as definitive treatment
  • Surgical Management other than the ones described in the inclusion criteria
  • Neglected Achilles Tendon Rupture (>3 weeks)
  • Bilateral Achilles Tendon Rupture
  • Patients operated before 2015
  • Comorbidities interfering with the secondary outcomes (e.g. Venous insufficiency resulting in lower limb excessive edema interferes with ankle and calf circumference, rheumatoid arthritis and/or previous foot and ankle surgery interferes with active and passive range of motion of the ankle, etc)
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Endoscopic Flexor Hallucis Longus transfer / Group 1

    Patients with acute Achilles tendon rupture managed with Endoscopic Flexor Hallucis Longus transfer by one surgeon (A.E.) in one hospital (General Hospital of Naoussa, Naoussa, Greece), all of which followed the same rehabilitation protocol.

    Procedure: Surgery for the treatment of Acute Achilles tendon rupture

  • Minimally Invasive Primary repair / Group 2

    Patients with acute Achilles tendon rupture managed with Minimally Invasive Primary repair by one surgeon (P.S.) in one hospital (St. Luke's Hospital, Thessaloniki, Greece), all of which followed the same rehabilitation protocol.

    Procedure: Surgery for the treatment of Acute Achilles tendon rupture

Interventions

  • ProcedureSurgery for the treatment of Acute Achilles tendon rupture

    Two different surgical techniques were applied in two different patient groups for the same disease. Their outcomes are evaluated and compared

06

What researchers measure

Primary outcomes

  1. Patient Satisfaction assessed with the Achilles Tendon Total Rupture Score

    Evaluated and quantified with the Achilles Tendon Total Rupture Score (minimum value = 0 - worst outcome, maximal value = 100 - best outcome)

    Time frame: More than 12 months postoperatively

Secondary outcomes

  1. Complication Rate

    Complications will be recorded and categorized: Rerupture, Infection, Nerve injury, Miscellaneous

    Time frame: More than 12 months postoperatively

  2. Calf Circumference

    Calf circumference measured 15 cm distally to the inferior pole of the patella. Contralateral limb calf circumference will also be measured. The Calf Circumference Difference will be calculated and compared between the two groups.

    Time frame: More than 12 months postoperatively

  3. Ankle Circumference

    Ankle circumference measured 8 cm proximally to the lateral malleolus. Contralateral limb ankle circumference will also be measured. The Ankle Circumference Difference will be calculated and compared between the two groups.

    Time frame: More than 12 months postoperatively

  4. Ankle joint Range of Motion

    Active and Passive Ankle joint Range of Motion will be calculated with an electronic goniometer. Contralateral limb Range of Ankle joint Motion will also be measured. The Range of Motion Difference will be calculated and compared between the two groups.

    Time frame: More than 12 months postoperatively

07

Study locations

1 site
  • General Hospital of Naoussa
    Náousa, Central Macedonia 59200, Greece
08

References and documents

Publications

  • Abdelatif NMN, Batista JP. Outcomes of Percutaneous Achilles Repair Compared With Endoscopic Flexor Hallucis Longus Tendon Transfer to Treat Achilles Tendon Ruptures. Foot Ankle Int. 2022 Sep;43(9):1174-1184. doi: 10.1177/10711007221096674. Epub 2022 Jun 10. PubMed 35686445 ↗
  • Abdelatif NMN, Batista JP. Endoscopic Flexor Hallucis Longus Transfer for the Management of Acute Achilles Tendon Ruptures in Professional Soccer Players. Foot Ankle Int. 2022 Feb;43(2):164-175. doi: 10.1177/10711007211036439. Epub 2021 Sep 24. PubMed 34558318 ↗
  • Batista JP, Abdelatif NMN, Del Vecchio JJ, Diniz P, Pereira H. Endoscopic Flexor Hallucis Longus Transfer for the Management of Acute Achilles Tendon Ruptures: A Prospective Case Series Report With a Minimum of 18 Months' Follow-Up. J Foot Ankle Surg. 2020 Sep-Oct;59(5):927-937. doi: 10.1053/j.jfas.2019.12.008. Epub 2020 Jun 9. PubMed 32527698 ↗
  • Martin KD, Crouser NJ, Khan IA. Minimally Invasive Mid-Substance Achilles Tendon Repair Using the Percutaneous Achilles Repair System (PARS). JBJS Essent Surg Tech. 2022 Sep 22;12(3):e21.00050. doi: 10.2106/JBJS.ST.21.00050. eCollection 2022 Jul-Sep. PubMed 36816527 ↗

Individual participant data

Plan to share: Undecided — The records of each patient to be enrolled belong to the respective surgeon (A.E. and P.S.). Thus, the records of each patient will be entrusted to the main researcher (M.K.) with the obligation to maintain doctor-patient confidentiality. The final study results will not reveal any sensitive patient data (de-identification). Photos and videos of each patient's examination may be taken after ensuring their written and oral informed consent.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06114368
Collaborators
General Hospital of Naoussa, Private Orthopedics Practice P. Symeonidis
Responsible party
Michail Kotsapas (Michail Kotsapas, MD, MSc, Resident of Orthopedics (General Hospital of Naoussa), PhD Candidate (Aristotle University of Thessaloniki), Aristotle University Of Thessaloniki) — Principal investigator
First posted
Nov 2, 2023
Start date
Mar 5, 2023
Primary completion
Mar 30, 2025 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
Oct 15, 2024

Study contacts

Michail K. Kotsapas, MD, MSc
principal investigator · Aristotle University Of Thessaloniki

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion